Cho, Heejin
Lee, Yun Bin
Ha, Yeonjung
Chon, Young Eun
Kim, Mi Na
Lee, Joo Ho
Park, Hana
Rim, Kyu Sung
Hwang, Seong Gyu
Funding for this research was provided by:
Gilead Sciences
Article History
Received: 14 September 2022
Accepted: 6 June 2023
First Online: 15 June 2023
Declarations
:
: The study protocol followed the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Institutional Review Boards of CHA Bundang Medical Center (IRB number: BD2014-178). The purpose of the study was fully stated to the participants and all participants signed a written informed consent.
: Not applicable.
: Dr. Lee YB reports receiving research grant from Samjin Pharmaceuticals and Yuhan Pharmaceuticals; Dr. Hwang SG reports receiving research grant from Gilead Sciences. No other potential conflict of interest relevant to this article was reported.